Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients

Summary

To determine whether once a day administration of Mesalamine is at least as safe and efficacious and administration of multiple doses a day in preventing clinical relapse of ulcerative colitis in children and adolescence.

Timeline

Start

2006-07

Primary completion

2011-01

Completion

2011-01

Outcome

Outcome not reported

Stopped (Enrollment): “none enrolled in second arm, therfore no analysis”

Drugs

Indications